Remove companies ikena-oncology-inc
article thumbnail

Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move

Benzinga

Ikena Oncology Inc (NASDAQ: IKNA ) acquired Pionyr Immunotherapeutics Inc , a privately-held biotechnology company, in an all-stock transaction. per share.

52
article thumbnail

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction

Benzinga

Ikena receives approximately $43 million in net cash at closing New capital will further accelerate and expand development of Ikena's targeted oncology pipeline BOSTON and SOUTH SAN FRANCISCO, Calif., 07, 2023 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. Chief Executive Officer of Ikena.

Equity 40